Mallory Cardenas
Family · Indianapolis, INNPI 1518687953
Payments from drug & device makers
Across 124 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$472
- Gilead$357
- Alkermes, Inc.$353
- Otsuka America Pharmaceutical, Inc.$255
- Johnson & Johnson$124
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$112
- plus $586 from 14 others
What the payments were for
- Food & beverage$2,260100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $472 |
| Gilead | 14 | $357 |
| Alkermes, Inc. | 14 | $353 |
| Otsuka America Pharmaceutical, Inc. | 22 | $255 |
| Johnson & Johnson | 6 | $124 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $112 |
| Vanda Pharmaceuticals Inc. | 6 | $107 |
| Neurocrine Biosciences, Inc. | 5 | $94 |
| Supernus Pharmaceuticals, Inc. | 3 | $73 |
| Indivior Inc. | 3 | $49 |
| Lundbeck LLC | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Exact Sciences | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,260 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 20 | $13,003 |
| Varenicline Tartrate | 11 | $3,184 |
| Metoprolol Succinate | 26 | $846 |
| Enalapril Maleate | 11 | $670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $567 |
| Atorvastatin Calcium | 72 | $508 |
| Tizanidine Hcl | 18 | $366 |
| Amlodipine Besylate | 44 | $313 |
| Levothyroxine Sodium | 27 | $309 |
| Metformin Hcl | 23 | $282 |
| Metformin Hcl ErMetformin Hcl | 48 | $259 |
| Omeprazole | 20 | $238 |
| Fluticasone Propionate | 15 | $220 |
| Ibuprofen | 12 | $217 |
| Potassium Chloride | 27 | $199 |
Paid to pharmacies, not to this prescriber.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.